Covidien closes VNUS purchase

Healthcare technology firm Covidien has completed its previously announced acquisition of VNUS Medical Technologies.

The Dublin, Ireland-based firm paid approximately $440 million for VNUS, which develops medical devices for minimally invasive treatment of venous reflux disease. VNUS will become part of the company's new Vascular Therapies global business unit, Covidien said.

Related Reading

Covidien to acquire VNUS for $440M, May 8, 2009

Covidien adds to Q2 sales, May 1, 2009

Covidien, B&W to tackle medical isotope dilemma, January 28, 2009

Covidien to move HQ to Ireland, January 7, 2009

Covidien shows gains in fiscal 2008, November 17, 2008

Copyright © 2009

Page 1 of 3591
Next Page